These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 25262382)

  • 1. Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
    Liu B; Miyake H; Nishikawa M; Fujisawa M
    Urol Oncol; 2015 Mar; 33(3):110.e11-8. PubMed ID: 25262382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
    Harada K; Miyake H; Kusuda Y; Fujisawa M
    BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cell cycle-associated proteins in non-muscle-invasive bladder cancer: correlation with intravesical recurrence following transurethral resection.
    Behnsawy HM; Miyake H; Abdalla MA; Sayed MA; Ahmed Ael-F; Fujisawa M
    Urol Oncol; 2011; 29(5):495-501. PubMed ID: 19914103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection.
    Muramaki M; Miyake H; Terakawa T; Kumano M; Sakai I; Fujisawa M
    Urol Oncol; 2012; 30(2):161-6. PubMed ID: 20451421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression patterns of epithelial-mesenchymal transition markers in localized prostate cancer: significance in clinicopathological outcomes following radical prostatectomy.
    Behnsawy HM; Miyake H; Harada K; Fujisawa M
    BJU Int; 2013 Jan; 111(1):30-7. PubMed ID: 23107154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
    Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
    Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy.
    Muramaki M; Miyake H; Terakawa T; Kusuda Y; Fujisawa M
    Urology; 2011 Dec; 78(6):1443.e7-12. PubMed ID: 21924460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial mesenchymal transition in urothelial carcinoma: twist in the tale.
    Paliwal P; Arora D; Mishra AK
    Indian J Pathol Microbiol; 2012; 55(4):443-9. PubMed ID: 23455777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin÷CD44 immunophenotype in the epithelial-mesenchymal transition of bladder urothelial carcinomas.
    Stepan AE; Pirici D; Bălăşoiu M; Novac MB; Drocaş AI; Ciurea RN; Stepan D; Gheonea DI; Simionescu CE
    Rom J Morphol Embryol; 2015; 56(1):85-91. PubMed ID: 25826491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?
    Park J; Song C; Shin E; Hong JH; Kim CS; Ahn H
    Urol Oncol; 2013 Aug; 31(6):849-56. PubMed ID: 21782482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the epithelial-to-mesenchymal transition markers e-cadherin, vimentin and twist in bladder cancer.
    Zhao J; Dong D; Sun L; Zhang G; Sun L
    Int Braz J Urol; 2014; 40(2):179-89. PubMed ID: 24856504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy.
    Kusuda Y; Miyake H; Terakawa T; Kondo Y; Miura T; Fujisawa M
    Urol Oncol; 2013 Aug; 31(6):899-903. PubMed ID: 21824792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era.
    Takaoka E; Matsui Y; Inoue T; Miyazaki J; Nakashima M; Kimura T; Oikawa T; Kawai K; Yoshimura K; Habuchi T; Ogawa O; Nishiyama H
    Jpn J Clin Oncol; 2013 Apr; 43(4):404-9. PubMed ID: 23444116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
    Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
    Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status.
    Fondrevelle ME; Kantelip B; Reiter RE; Chopin DK; Thiery JP; Monnien F; Bittard H; Wallerand H
    Urol Oncol; 2009; 27(3):268-76. PubMed ID: 18440840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors.
    Baumgart E; Cohen MS; Silva Neto B; Jacobs MA; Wotkowicz C; Rieger-Christ KM; Biolo A; Zeheb R; Loda M; Libertino JA; Summerhayes IC
    Clin Cancer Res; 2007 Mar; 13(6):1685-94. PubMed ID: 17363521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.